The landscape of dementia analysis has progressed considerably with the appearance of advanced biomarkers, like amyloid PET scans, tau imaging, and blood-dependent assessments which can detect Alzheimer's pathology years before signs and symptoms arise. When these technological improvements depict extraordinary development in understanding neurodeg